Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Moderna Stock: Bull vs. Bear

TheMotleyFool

0 0

There's good news and bad news for Moderna (NASDAQ: MRNA) investors. The good news is that shares of the messenger RNA (mRNA) vaccine maker have skyrocketed over 1,100% since the beginning of 2020. The bad news is that Moderna has given up a lot of its gains with the stock plunging close to 50% below its high from earlier this year.

But is this beaten-down vaccine stock a buy now? Two Motley Fool contributors have different takes on Moderna.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Teilen